Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatorymahaadverse-eventsgray-marketfda

Patients reporting peptide harms say voices lost amid MAHA medical-freedom push

The report describes people who attribute injuries to peptide use and say their accounts get little attention as deregulation advocates press for wider access.

DO
By Daniel Okafor · Regulatory Correspondent
Oct 17 21:47 ETSource: PressReader

The wire

  1. 01The piece collects accounts from people who say peptide products hurt them, set against the MAHA movement's campaign for looser restrictions on access.
  2. 02Clinicians and compounders fielding patient questions about gray-market peptides face a widening gap between harm reports and the political push for availability.
  3. 03The accounts are individual reports rather than systematic safety data, and no regulatory action is described in the piece.

From the source

People say peptides hurt them, but their stories are muffled in MAHA push for medical freedom

Read at pressreader.com
PeptiPrescribed peptides from $99/moSee all →